Key result
Metabolic inhibition reduced action potential duration by 80% in epicardial cells versus 13% in endocardial cells, and peak Ca2+ current by 37% versus 21% (p<0.01).
Why the study?
Does metabolic inhibition affect action potentials and calcium currents differently in endocardial versus epicardial cells?
Does metabolic inhibition affect action potentials and calcium currents differently in endocardial versus epicardial cells?
p-value: p=<0.01
Metabolic inhibition causes greater depression of the Ca2+ current and action potential shortening in epicardial cells compared to endocardial cells, which may explain ischemia-induced electrophysiological changes.
May explain epicardial predominance in ischemic arrhythmias; leaves open human translation.
BACKGROUND: Ischemia-induced electrophysiological changes are more prominent in epicardial cells than in endocardial cells. Epicardial action potentials shorten more than endocardial action potentials during ischemia. Since the L-type Ca2+ current plays an important role in the maintenance of action potential duration, we hypothesized that the Ca2+ current is affected more in epicardial cells than in endocardial cells during ischemia. METHODS AND RESULTS: To test this hypothesis, we examined the effect of metabolic inhibition, a major component of ischemia, on action potentials and the Ca2+ current in single cells isolated from the endocardial and epicardial layers of the feline left ventricle. The membrane voltage and current were measured by using the whole-cell mode of the patch-clamp technique. During control periods, action potentials recorded from epicardial myocytes had lower amplitude, a prominent notch between phases 1 and 2, and shorter action potential duration compared with those recorded from endocardial myocytes. However, the amplitude and current-voltage relation of the Ca2+ current were similar in endocardial and epicardial cells at test potentials of -30 to 60 mV elicited from a holding potential of -40 mV. The time course of inactivation of the Ca2+ current also was identical in the two cell types. After 15 minutes of superfusion with glucose-free Tyrode's solution containing 1 mM CN-, action potential duration was reduced by 13 +/- 7% in endocardial cells and by 80 +/- 9% in epicardial cells (p less than 0.01). The peak Ca2+ current was reduced by 21 +/- 9% in endocardial cells and by 37 +/- 6% in epicardial cells (p less than 0.01). CONCLUSIONS: We conclude that enhanced depression of the Ca2+ current may account in part for the greater action potential shortening in epicardial cells during ischemia and metabolic inhibition.
No takes yet. Share an insight, caveat, or question.
Kimura et al. (1991) studied Ischemia. Metabolic inhibition (glucose-free Tyrode's solution with CN-) vs. Endocardial cells (compared to epicardial cells) was evaluated on Reduction in action potential duration and peak Ca2+ current (p=<0.01). Metabolic inhibition reduced action potential duration by 80% in epicardial cells versus 13% in endocardial cells, and peak Ca2+ current by 37% versus 21% (p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: